the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid.
.
.
.
plemmons and co-authors disclosed no relevant relationships with industry.
.
.
.
.
.
.
crispr therapeutics, mgh team up on new cancer treatments
.
schneider said that he is hoping to conduct a subsequent study of 15 to 20 pregnancies and that he is encouraged by these results.
.
.